Hellen Berger is a business writer based in Sao Paulo, Brazil.
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator. Hellen Berger reports.
New regulation offers drug options for patients with rare, severe, or debilitating illnesses.
Brazil's deal to produce a generic version of a BMS AIDS drug has met with resistance — but the health ministry remains defiant. Hellen Berger reports.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva